These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 2371841)

  • 1. A new immune-modulatory substance:CH-27584.
    Guczoghy L; Vértesi C; Gergely P; Szende B; Körmöczy PS
    Acta Physiol Hung; 1990; 75 Suppl():131-2. PubMed ID: 2371841
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody responses and regulation. A role for natural killer cells.
    Robles CP; Pollack SB
    Nat Immun Cell Growth Regul; 1986; 5(2):64-74. PubMed ID: 2941681
    [No Abstract]   [Full Text] [Related]  

  • 3. Heparin enhances generation of natural killer activity in vitro.
    Wasik M; Górski A
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):73-6. PubMed ID: 7503640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulative effects of aflatoxins and selenium on human natural killer cells.
    Methenitou G; Maravelias C; Athanaselis S; Dona A; Koutselinis A
    Vet Hum Toxicol; 2001 Aug; 43(4):232-4. PubMed ID: 11474740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of Eleuterococcus senticosus on cellular and humoral immunological response of mice.
    Rogala E; Skopińska-Rózewska E; Sawicka T; Sommer E; Prosińska J; Drozd J
    Pol J Vet Sci; 2003; 6(3 Suppl):37-9. PubMed ID: 14509359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
    Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
    Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of natural killer cells with 3,6-bis (2-piperidinoethoxy) acridine trihydrochloride (CL 246, 738).
    Wang BS; Lumanglas AL; Veronica JS; Ruszala-Mallon M; Durr FE
    Chin Med J (Engl); 1987 Mar; 100(3):192-7. PubMed ID: 3113840
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulating activity of pidotimod.
    Migliorati G; Nicoletti I; Riccardi C
    Arzneimittelforschung; 1994 Dec; 44(12A):1421-4. PubMed ID: 7857335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of polyclonal immune stimulators upon NZB.xid congenic mice.
    Smathers PA; Steinberg BJ; Reeves JP; Steinberg AD
    J Immunol; 1982 Mar; 128(3):1414-9. PubMed ID: 6976992
    [No Abstract]   [Full Text] [Related]  

  • 10. Heat shock protein 90 inhibitor BIIB021 (CNF2024) depletes NF-kappaB and sensitizes Hodgkin's lymphoma cells for natural killer cell-mediated cytotoxicity.
    Böll B; Eltaib F; Reiners KS; von Tresckow B; Tawadros S; Simhadri VR; Burrows FJ; Lundgren K; Hansen HP; Engert A; von Strandmann EP
    Clin Cancer Res; 2009 Aug; 15(16):5108-16. PubMed ID: 19671844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro effect of gonadotropin-releasing hormone agonist on natural killer cell cytolysis in women with and without endometriosis.
    Wong KH; Simon JA
    Am J Obstet Gynecol; 2004 Jan; 190(1):44-9. PubMed ID: 14749633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulating properties of corticotropin-releasing factor.
    Singh VK
    Adv Exp Med Biol; 1991; 303():289-93. PubMed ID: 1805574
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of adjuvants on biosynthesis of 19S and 7S antibody against bacteriophage phiX174 in the guinea-pig.
    Wilkinson PC; Fleming WA; White RG
    Immunology; 1967 Dec; 13(6):603-11. PubMed ID: 6065018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations.
    van Ojik HH; Bevaart L; Dahle CE; Bakker A; Jansen MJ; van Vugt MJ; van de Winkel JG; Weiner GJ
    Cancer Res; 2003 Sep; 63(17):5595-600. PubMed ID: 14500400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells.
    Nguyen QH; Roberts RL; Ank BJ; Lin SJ; Thomas EK; Stiehm ER
    Cell Immunol; 1998 May; 185(2):83-92. PubMed ID: 9636686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of T-activin on human natural killer activity in vitro].
    Cheknev SB; Saidov MZ; Koval'chuk LV; Pavliuk AS; Arion VIa
    Biull Eksp Biol Med; 1986 Apr; 101(4):455-7. PubMed ID: 3457607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator.
    Humphries MJ; Matsumoto K; White SL; Molyneux RJ; Olden K
    Cancer Res; 1988 Mar; 48(6):1410-5. PubMed ID: 3125963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.
    Kikuchi A; Nieda M; Schmidt C; Koezuka Y; Ishihara S; Ishikawa Y; Tadokoro K; Durrant S; Boyd A; Juji T; Nicol A
    Br J Cancer; 2001 Sep; 85(5):741-6. PubMed ID: 11531261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen induces suppression of natural killer cell cytotoxicity and augmentation of polyclonal B cell activation.
    Nilsson N; Carlsten H
    Cell Immunol; 1994 Oct; 158(1):131-9. PubMed ID: 8087860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.